Author:
Teachey David T.,Bishop Michael R.,Maloney David G.,Grupp Stephan A.
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Neelapu, S. S. et al. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities. Nat. Rev. Clin. Oncol. 15, 47–62 (2018).
2. Hough, R. et al. Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003. Br. J. Haematol. 172, 439–451 (2016).
3. Wildes, T. M., Goede, V. & Hamlin, P. Personalizing therapy for older adults with lymphoid malignancies: options and obstacles. Am. Soc. Clin. Oncol. Educ. Book, e240–e248 (2014).
4. Porter, D. L. et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci. Transl Med. 303, ra139 (2015).
5. Buechner, J. et al. Global registration trial of efficacy and safety of CTL019 in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia: an update to the interim analysis. in 22nd Congress of the European Hematology Association S476 (Madrid, Spain, 2017).
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献